Skip to main content
SpringerLink
Log in

Molekulare Hochdurchsatzforschung beim Prostatakarzinom

  • Leitthema
  • Published:
Der Urologe Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1
Abb. 2

Literatur

  1. Schlomm T, Erbersdobler A, Mirlacher M, Sauter G (2007) Molecular staging of prostate cancer in the year 2007. World J Urol 25: 19–30

    Article  PubMed  CAS  Google Scholar 

  2. Arlt D, Huber W, Liebel U et al. (2005) Functional profiling: from microarrays via cell-based assays to novel tumor relevant modulators of the cell cycle. Cancer Res 65: 7733–7742

    Article  PubMed  CAS  Google Scholar 

  3. Holst F, Stahl PR, Ruiz C et al. (2007) Estrogen receptor alpha (ESR1) gene amplification is frequent in breast cancer. Nat Genet 39(5): 655–660

    Article  PubMed  CAS  Google Scholar 

  4. Schlomm T, Luebke AM, Sultmann H et al. (2005) Extraction and processing of high quality RNA from impalpable and macroscopically invisible prostate cancer for microarray gene expression analysis. Int J Oncol 27: 713–720

    PubMed  CAS  Google Scholar 

  5. Schlomm T, Naekel E, Lubke A et al. (2007) Marked gene transcript alterations occur early during radical prostatectomy. Eur Urol (in press)

  6. Schlomm T, Iwers L, Kirstein P et al. (2007) Rare p53 alterations have high prognostic relevance in early stage prostate cancers. Int J Cancer (in press)

  7. Kononen J, Bubendorf L, Kallioniemi A et al. (1998) Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 4: 844–847

    Article  PubMed  CAS  Google Scholar 

  8. Schlomm T, Hellwinkel OJ, Buness A et al. (2007) Molecular cancer phenotype in histologically normal prostate tissue. (submitted)

  9. Schlomm T, Iwers L, Mirlacher M et al. (2007) Low level HER2 expression is associated with rapid tumor cell proliferation and poor prognosis in prostate cancer. (submitted)

  10. Schlomm T, Iwers L, Kirstein P et al. (2007) Clinical significance of EGFR protein over expression and gene copy number gains in prostate cancer. (submitted)

  11. Schlomm T, Petersen A, Kramme I et al. (2007) Alterations of the physiological PSMA expression patterns are associated with poor prognosis in prostate cancer.Clin Cancer Res (in press)

  12. Paez JG, Janne PA, Lee JC et al. (2004) EGFR Mutations in lung cancer: Correlation with clinical response to Gefitinib therapy. Science 304: 1497–1500

    Article  PubMed  CAS  Google Scholar 

  13. Lynch TJ, Bell DW, Sordella R et al. (2004) Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 350: 2129–2139

    Article  PubMed  CAS  Google Scholar 

  14. Menard S, Casalini P, Campiglio M et al. (2001) HER2 overexpression in various tumor types, focussing on its relationship to the development of invasive breast cancer. Ann Oncol 12(Suppl 1): 15–19

    Article  Google Scholar 

  15. Scholl S, Beuzeboc P, Pouillart P (2001) Targeting HER2 in other tumor types. Ann Oncol 12(Suppl 1): 81–87

    Article  Google Scholar 

  16. Tapia C, Glatz K, Novotny H et al. (2007) Close association between HER-2 amplification and overexpression in human tumors of non-breast origin. Mod Pathol 20: 192–198

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Martini-Klinik am UKE, Universitätsklinikum Hamburg-Eppendorf, Martinistraße 52, Gebäude O46, 20246, Hamburg, Deutschland

    T. Schlomm, O.J.C. Hellwinkel & H. Huland

  2. Urologische Klinik, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Deutschland

    T. Schlomm & H. Huland

  3. Abteilung für Molekulare Genomanalyse, Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Deutschland

    H. Sültmann & A. Poustka

  4. Institut für Pathologie, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Deutschland

    G. Sauter

Authors
  1. T. Schlomm
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. Sültmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Poustka
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. G. Sauter
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. O.J.C. Hellwinkel
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. H. Huland
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to T. Schlomm.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schlomm, T., Sültmann, H., Poustka, A. et al. Molekulare Hochdurchsatzforschung beim Prostatakarzinom. Urologe 46, 1097–1100 (2007). https://doi.org/10.1007/s00120-007-1440-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00120-007-1440-4

Search

Navigation